leisure time -WSS

leisure time

author：explore 2025-10-02 17:27:46 - browse：9

Are venture capitalists OK? Are bolt-ons good for business? And when is it safe to say someone overpaid?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how biotech’s downturn has made life difficult not just for startups but also the VCs they rely on for much-needed funding. We also take a look at Gilead Sciences’ struggle to turn itself into an oncology company and the latest biotech to get bought out by a major pharma firm.

For more on what we cover, here’s more on Gilead; here’s the news on Inhibrx; here’s the latest on biotech venture capital; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： How to increase colonoscopy rates? Looks like an AI can help

focus

WSS

Johnson & Johnson sued for allegedly overpaying for workers' drugs

BMI, flaws aside, is found to be useful estimate of body fat in youth

Change Healthcare can notify patients about the breach, HHS says

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Padmanee Sharma of MD Anderson at center of lawsuit over credit

FDA's Pazdur wants cancer trials to range beyond China alone

knowledge

leisure time

knowledge

Guidelines to prevent youth baseball injuries need more muscle

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Guidelines to prevent youth baseball injuries need more muscle

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Anesthesiologist group: stop taking Ozempic before surgery

A protest over insulin prices is seen as a fight for life

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Hepatitis C has a cure — but many Americans still lack access to it

Innovation in antibiotics is ailing. 'Brain drain' may kill it

explore

The Pandemic Treaty must support building strong health systems

Change Healthcare can notify patients about the breach, HHS says

The Biogen Aduhelm mess could happen again

Medicare Advantage plans can’t deny care with AI, CMS warns

Woman returns to dialysis after doctors remove transplanted pig kidney

Woman returns to dialysis after doctors remove transplanted pig kidney

hotspot

explore

focus

explore